Showing 36,661 - 36,680 results of 66,758 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((nn decrease) OR (mean decrease)) ))', query time: 1.22s Refine Results
  1. 36661

    Effects of PPS on the expression of glutamic acid decarboxylase 65/67 (GAD6) in the amygdala of rats. by Stamatina Tzanoulinou (552258)

    Published 2014
    “…Optical densitometry of neuropil immunoreactivity revealed a significant decrease of GAD protein levels in the amygdala of PPS animals as compared to CTRL (D). ** p<0.01 versus CTRL, results are the mean ± SEM.…”
  2. 36662
  3. 36663
  4. 36664
  5. 36665

    Molecular mechanisms of impaired intestinal barrier function. by Tim Vanuytsel (513970)

    Published 2014
    “…(E) Western Blot analysis at 50 days shows decreased CLDN1 expression and a tendency towards increased CLDN2 expression (P = 0.07) in BB-DP rats (white bars) compared to controls (black bars). …”
  6. 36666

    Table1_Storax Inhibits Caveolae-Mediated Transcytosis at Blood-Brain Barrier After Ischemic Stroke in Rats.DOCX by Min Zhou (173135)

    Published 2022
    “…Storax treatment of 0.2, 0.4, and 0.8 g/kg led to a significant decrease in infarction size, and the Storax 0.4, 0.8 g/kg groups displayed a significant reduction in brain water content. …”
  7. 36667

    FRAP analysis reveals PFN1 as major regulator of actin dynamics in astrocytic processes. by Stefanie K. Schweinhuber (687289)

    Published 2015
    “…Significance is indicated as follows *p<0.05; **p<0.01; ***p<0.001. Data are shown as mean ± SEM.…”
  8. 36668
  9. 36669
  10. 36670
  11. 36671
  12. 36672
  13. 36673
  14. 36674
  15. 36675
  16. 36676
  17. 36677
  18. 36678
  19. 36679

    Results linear mixed model on factors predicting change in saturation, heart frequency, systolic and diastolic blood pressure. by Edwin J. van Adrichem (830745)

    Published 2015
    “…Example: saturation is expected to be 9.7% less at an altitude of 4680 meters and, with every year that someone is older a decrease in saturation of 0.1% is expected.</p><p>Results linear mixed model on factors predicting change in saturation, heart frequency, systolic and diastolic blood pressure.…”
  20. 36680

    DataSheet_1_Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.docx by Patricia T. Illing (6746918)

    Published 2021
    “…<p>Abacavir hypersensitivity syndrome can occur in individuals expressing the HLA-B*57:01 major histocompatibility complex class I allotype when utilising the drug abacavir as a part of their anti-retroviral regimen. …”